Related Experiment Video
Updated: Aug 19, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
[Vaccination schedule of the Spanish Association of Pediatrics: recommendations 2005]
Insights
The Spanish Association of Pediatrics updates its 2005 immunization schedule, recommending booster doses for meningococcal C and pertussis vaccines in adolescents and children. Hexavalent vaccines remain recommended.
Area of Science:
- Pediatrics
- Vaccinology
- Immunology
Context:
- The Spanish Association of Pediatrics' Advisory Committee on Vaccines reviews 2004 vaccine developments.
- Key modifications are proposed for the 2005 immunization schedule.
Purpose:
- To provide updated recommendations on vaccine schedules and usage.
- To address specific vaccine concerns, including meningococcal C and hexavalent vaccines.
Summary:
- No changes to the two-dose primary vaccination for meningococcal C vaccine.
- Discussion on immunization failures with three doses before 12 months, anticipating a 2005 booster.
- Continued validity of European Medicines Evaluation Agency recommendations for hexavalent vaccines.
- Emphasis on adolescent booster doses for pertussis, combined with adult diphtheria and tetanus vaccines.
Impact:
- Informs healthcare providers about crucial updates to pediatric immunization schedules.
- Ensures optimal vaccine efficacy and addresses potential immunization failures.
- Supports evidence-based vaccine administration practices for improved public health outcomes.
Abstract:
The Advisory Committee on Vaccines of the Spanish Association of Pediatrics provides information and comments on the new developments in vaccines that have taken place in 2004 and recommends a few modifications to the Immunization Schedule for 2005. Concerning the meningococcal C vaccine, no change is made to the possibility of administering two doses for the first vaccination with one of the available formulations. The existence of immunization failure in children who have received a first vaccination with three vaccine doses before the age of 12 months is discussed, and the health authorities will probably include a booster dose in the second year of life throughout 2005. The recommendations of the European Medicines Evaluation Agency (EMEA) on hexavalent vaccines continue to be valid and consequently the use of these vaccines should not be stopped. This year the need for adolescents to receive a booster dose of the pertussis vaccine, with administration of an acellular, low antigenic load preparation together with the adult diphtheria and tetanus vaccine is stressed.
Related Concept Videos
Vaccinations
Drug Dosing: Infants and Children
Vaccines
Smallpox
Preventive Healthcare Services
Respiratory Syncytial Virus Disease

